This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Solum, N. O. Search for Related Content PubMed PubMed Citation Articles by Solum, N. O. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information Bleeding Disorders Related Collections Growth factors/cytokines Coagulation and fibronolysis Platelets

(Arteriosclerosis, Thrombosis, and Vascular Biology. 1999;19:2841.)
© 1999 American Heart Association, Inc.

Brief Reviews

Procoagulant Expression in Platelets and Defects Leading to Clinical Disorders

Nils Olav Solum

From the Research Institute for Internal Medicine, Rikshospitalet, University of Oslo, Oslo, Norway.

Correspondence to Nils Olav Solum, Research Institute for Internal Medicine, Rikshospitalet, Pilestredet 32, 0027 Oslo, Norway. E-mail n.o.solum{at}rh.uio.no

Abstract—Hemostasis is a result of interactions between fibrillar structures in the damaged vessel wall, soluble components in plasma, and cellular elements in blood represented mainly by platelets and platelet-derived material. During formation of a platelet plug at the damaged vessel wall, factors IXa and VIIIa form the "tenase" complex, leading to activation of factor X on the surface of activated platelets. Subsequently, factors Xa and Va form the "prothrombinase" complex, which catalyzes the formation of thrombin from prothrombin, leading to fibrin formation. An enhanced expression of negatively charged phosphatidylserine in the outer membrane leaflet resulting from a breakdown of the phospholipid asymmetry is essential for the formation of the procoagulant surface. An ATP-driven and inward-acting aminophospholipid "translocase" and a "floppase" counterbalancing this have been postulated to maintain the dynamic state of phospholipid asymmetry. A phospholipid-nonspecific "scramblase," believed to be responsible for the fast breakdown of the asymmetry during cell activation, has recently been isolated from erythrocytes, cloned, and characterized. An intracellular calcium-binding segment and one or more thioesterified fatty acids are probably of importance for calcium-induced activation of this transporter protein. Cytosolic calcium ions also activate the calcium-dependent protease calpain associated with shedding of microvesicles from the transformed platelet membrane. These are shed with a procoagulant surface and with surface-exposed P-selectin from the -granules. Theoretically, therefore, microvesicles can be involved in both coagulation and inflammation. Scott syndrome is probably caused by a defect in the activation of an otherwise normal scramblase, resulting in a relatively severe bleeding tendency. In Stormorken syndrome, the patients demonstrate a spontaneous surface expression of aminophospholipids. Activated platelets and the presence of procoagulant microvesicles have been demonstrated in several clinical conditions, such as thrombotic and idiopathic thrombocytopenia, disseminated intravascular coagulation, and HIV-1 infection, and have been found to be associated with fibrin in thrombosis. Procoagulant microvesicles may also be formed from other cells as a result of apoptosis.

Key Words: microvesicles • platelets • coagulation • hemostasis

This article has been cited by other articles:

				S. K. Dasgupta, H. Abdel-Monem, P. Niravath, A. Le, R. V. Bellera, K. Langlois, S. Nagata, R. E. Rumbaut, and P. Thiagarajan Lactadherin and clearance of platelet-derived microvesicles Blood, February 5, 2009; 113(6): 1332 - 1339. [Abstract] [Full Text] [PDF]

				K. Fischer, S. Voelkl, J. Berger, R. Andreesen, T. Pomorski, and A. Mackensen Antigen recognition induces phosphatidylserine exposure on the cell surface of human CD8+ T cells Blood, December 15, 2006; 108(13): 4094 - 4101. [Abstract] [Full Text] [PDF]

				M. Jayachandran, K. Karnicki, R. S. Miller, W. G. Owen, K. S. Korach, and V. M. Miller Platelet Characteristics Change With Aging: Role of Estrogen Receptor {beta} J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 815 - 819. [Abstract] [Full Text] [PDF]

				M. Ferenac, D. Polancec, M. Huzak, O. M. Pereira-Smith, and I. Rubelj Early-Senescing Human Skin Fibroblasts Do Not Demonstrate Accelerated Telomere Shortening J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(7): 820 - 829. [Abstract] [Full Text] [PDF]

				I. del Conde, F. Nabi, R. Tonda, P. Thiagarajan, J. A. Lopez, and N. S. Kleiman Effect of P-Selectin on Phosphatidylserine Exposure and Surface-Dependent Thrombin Generation on Monocytes Arterioscler Thromb Vasc Biol, May 1, 2005; 25(5): 1065 - 1070. [Abstract] [Full Text] [PDF]

				B. OSTERUD and E. BJORKLID Role of Monocytes in Atherogenesis Physiol Rev, October 1, 2003; 83(4): 1069 - 1112. [Abstract] [Full Text] [PDF]

				D. M. Monroe, M. Hoffman, and H. R. Roberts Platelets and Thrombin Generation Arterioscler Thromb Vasc Biol, September 1, 2002; 22(9): 1381 - 1389. [Abstract] [Full Text] [PDF]

				M. B. Brooks, J. L. Catalfamo, H. A. Brown, P. Ivanova, and J. Lovaglio A hereditary bleeding disorder of dogs caused by a lack of platelet procoagulant activity Blood, April 1, 2002; 99(7): 2434 - 2441. [Abstract] [Full Text] [PDF]

				J. H. M. Smits, J. van der Linden, P. J. Blankestijn, and T. J. Rabelink Coagulation and haemodialysis access thrombosis Nephrol. Dial. Transplant., November 1, 2000; 15(11): 1755 - 1760. [Full Text] [PDF]